Acquired angioedema associated with chronic hepatitis C

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 4, 1999, Pages 711-712

  Farkas, Henriette ^a   Csepregi, Antal ^a   Nemesánszky, Elmér ^a   Pár, Alajos ^c   Gyeney, László ^a   Varga, Lilian ^b   Füst, George ^d  

^a National Institute of Rheumatology Budapest   (Hungary)

^b National Institute of Haematology and Immunology Budapest   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL;

ADULT; ANGIONEUROTIC EDEMA; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CASE REPORT; COMPLEMENT FACTOR; DISEASE ASSOCIATION; FEMALE; HEMOLYSIS; HEPATITIS C; HUMAN; LIVER FUNCTION; LIVER HISTOLOGY; PRIORITY JOURNAL;

EID: 0033055696     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70248-4     Document Type: Article

References (5)

1. 1. Agostini A, Cicardi M, Hereditary and acquired Cl-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992;71:206-15.
2. 2. Pawlotsky JM, Yahia MB, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19:841-8.
3. 3. Knodell RG, Ishak KG, Black WC. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
4. 4. Nelson RA Jr, Jensen J, Gigli I, Tamura M. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea pig serum. Immunochemistry 1966;3:111-35.
5. 5. Cicardi M, Beretta A, Colombo M, Gioffré D, Cugno M, Agostonia A. Relevance of lymphoproliferative disorders and of anti-Cl inhibitor autoantibodies in acquired angioedema. Clin Exp Immunol 1996;106:475-80.